SSA
XENT

Schonfeld Strategic Advisors’s Intersect ENT, Inc XENT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-101,480
Closed -$1.38M – 1771
2020
Q2 		$1.38M Buy
101,480
+80,863
+392% +$941K 0.04% 513
2020
Q1 		$244K Sell
20,617
-5,870
-22% -$130K 0.02% 837
2019
Q4 		$660K Sell
26,487
-20,613
-44% -$418K 0.02% 640
2019
Q3 		$801K Sell
47,100
-57,900
-55% -$1.05M 0.02% 526
2019
Q2 		$2.39M Buy
+105,000
New +$2.83M 0.08% 259

Other funds holding XENT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Schonfeld Strategic Advisors's XENT Position: Q3 2020 in Review

Schonfeld Strategic Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 101,480 shares — an estimated $1.38M sold.

Schonfeld Strategic Advisors first reported a position in XENT in Q2 2019 and held it in 5 quarters. The position peaked at $2.39M in Q2 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

  • Schonfeld Strategic Advisors reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 101,480 Intersect ENT, Inc shares in Q3 2020, an estimated $1.38M.
  • Schonfeld Strategic Advisors first reported a position in Intersect ENT, Inc in Q2 2019 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Intersect ENT, Inc position peaked at $2.39M in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.